ProNAi Therapeutics Strengthens Senior Management Team to Advance DNAi®-based Oncology Therapeutics

 Vancouver, BC, Canada and Plymouth, MI, USA – October 22, 2014. ProNAi Therapeutics Inc., a private company dedicated to developing and commercializing a new class of therapies based on its proprietary DNAi® platform, today announced that it has added five seasoned executives to its senior management team.

  • Dr. Angie You, Chief Business & Strategy Officer & Head of Commercial
  • Wendy Chapman, Senior Vice President, Clinical Operations
  • Chandra Lovejoy, Senior Vice President, Global Regulatory Affairs & Quality
  • Emma McCann, Vice President, Program Management
  • James Smith, Vice President, Corporate Affairs

Read More:  ProNAi Therapeutics Strengthens Senior Management Team to Advance DNAi®-based Oncology Therapeutics